4:43 PM
 | 
Apr 04, 2013
 |  BC Extra  |  Company News

Accord suing Acorda for Ampyra samples

Generics company Accord Healthcare Inc. (Durham, N.C.) filed suit in the U.S. District Court for the Southern District of Florida against Acorda Therapeutics Inc. (NASDAQ:ACOR) alleging Acorda is violating antitrust laws by refusing to provide samples of Ampyra dalfampridine for bioequivalence testing. Accord is developing a generic version of the...

Read the full 237 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >